Linfang Wang Selected Research

1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazine

10/2021	Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study.
1/2019	Response and acquired resistance to savolitinib in a patient with pulmonary sarcomatoid carcinoma harboring MET exon 14 skipping mutation: a case report.
1/2015	Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linfang Wang Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2012
6	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2012
4	Carcinogenesis 01/2022 - 01/2012
4	Infertility (Sterility) 04/2016 - 05/2006
3	Carcinoma (Carcinomatosis) 10/2021 - 01/2014
3	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2021
2	Disease Progression 10/2021 - 01/2019
2	Pathologic Processes 12/2019 - 01/2019
1	Central Nervous System Neoplasms 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Glioma (Gliomas) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 11/2021
1	Adenocarcinoma 11/2021
1	Tumor Lysis Syndrome 10/2021
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Left Ventricular Dysfunction 01/2020
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Esophageal Neoplasms (Esophageal Cancer) 08/2017
1	Female Infertility 03/2016
1	Colitis-Associated Neoplasms 08/2015
1	Vascular Diseases (Vascular Disease) 08/2015
1	Vascular System Injuries 08/2015
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Insulin Resistance 12/2012
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2012
1	Herpes Zoster 09/2006
1	Alzheimer Disease (Alzheimer's Disease) 01/2006

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2006
4	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2012
4	AntibodiesIBA 04/2016 - 12/2009
3	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 10/2021 - 01/2015
3	Indicators and Reagents (Reagents)IBA 08/2020 - 04/2016
2	Biological ProductsIBA 01/2022 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2020 - 08/2015
2	Peroxynitrous Acid (Peroxynitrite)IBA 07/2020 - 01/2018
2	Glutathione (Reduced Glutathione)IBA 12/2019 - 03/2018
2	Peptides (Polypeptides)IBA 03/2018 - 09/2006
2	Fluorescent Dyes (Fluorescent Probes)IBA 03/2018 - 01/2018
1	Pharmaceutical PreparationsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	curzereneIBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2022
1	camrelizumabIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 08/2020
1	Hypochlorous Acid (Hypochlorite)IBA 07/2020
1	ORALIT (ORS)IBA 01/2020
1	Thyroid HormonesIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019
1	Cyclin-Dependent Kinase 2IBA 10/2018
1	Estrogen ReceptorsIBA 10/2018
1	Organic Anion TransportersIBA 03/2018
1	AnionsIBA 03/2018
1	LigandsIBA 03/2018
1	Cysteine (L-Cysteine)FDA Link 03/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	ErbB Receptors (EGF Receptor)IBA 08/2017
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2017
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 04/2016
1	Tumor Biomarkers (Tumor Markers)IBA 08/2015
1	Serine Proteases (Serine Protease)IBA 08/2015
1	Hemin (Panhematin)FDA Link 08/2015
1	Heme Oxygenase-1IBA 08/2015
1	AntioxidantsIBA 08/2015
1	SmokeIBA 08/2015
1	CateninsIBA 01/2013
1	Lysine (L-Lysine)FDA Link 01/2013
1	Calcibiotic Root Canal SealerIBA 01/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2012
1	EnzymesIBA 01/2012
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2012

Therapy/Procedure

6	Therapeutics 10/2021 - 08/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Radiotherapy 11/2021 - 02/2018
1	Chemoradiotherapy 11/2021
1	Colectomy 01/2014